End-stage renal disease secondary to autosomal dominant poly-cystic kidney (ADPKD) is a common issue worldwide. Peritoneal dialysis (PD) is a reasonable option for renal replacement therapy for these patients and should not be withheld due to concerns that the patient may not tolerate the fluid volumes in the peritoneal cavity. This review covers the existing data on the outcomes and complications associated with the use of PD in the polycystic kidney disease patient. In general, PD is well tolerated and outcomes in ADPKD patients are equivalent to or better than other patient groups.
SpithovenE.M., KramerA., MeijerE., OrskovB., WannerC., AbadJ.M.Renal replacement therapy for autosomal dominant polycystic kidney disease (ADPKD) in Europe: prevalence and survival—an analysis of data from the ERA-EDTA Registry.Nephrol Dial Transplant2014; 29: iv15–25.
3.
US Renal Data System.2015 Annual Data Report.Am J Kidney Dis2016; 67(3): A1–S434.
GabowP.A.Factors affecting the progression of renal disease in autosomal-dominant polycystic kidney disease.Kidney Int1992; 41: 1311–9.
6.
Del PescoG., BajoM.A., CosteroO., HeviaC., GilF., DíazC.Risk factors for abdominal wall complications in peritoneal dialysis patients.Perit Dial Int2003; 23: 249–54.
7.
De VecchiA.F., ScalamognaA., ScanzianiR., CastelnovoC., DozioB., RovereG.Polycystic kidney disease and later peritoneal leakage in CAPD: are they related?Perit Dial Int2002; 22: 82–4.
8.
FletcherS., TurneyJ.H., BrownjohnA.M.Increased incidence of hydrothorax complicating peritoneal dialysis in patients with adult polycystic kidney disease.Nephrol Dial Transplant1994; 9: 832–3.
GoffinE., PirsonY.Is peritoneal dialysis a suitable renal replacement therapy in autosomal dominant polycystic kidney disease?Nat Clin Pract Nephrol2009; 5: 122–3.
12.
HadimeriH., JohanssonA.C., HaraldssonB., NybergG.CAPD in patients with autosomal dominant polycystic kidney disease.Perit Dial Int1998; 18: 429–32.
13.
PandyaB., FriedeT., WilliamsJ.A comparison of peritonitis in polycystic and non-polycystic patients on peritoneal dialysis.Perit Dial Int2004; 24: 79–81.
14.
KumarS., FanS.L.S., RafteryM.J., YaqoobM.M.Long-term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis.Kidney Int2008; 74: 946–51.
15.
LiL., SzetoC.C., KwanB.C., ChowK.M., LeungC.B., Kam-Tao LiP.Peritoneal dialysis as the first-line renal replacement therapy in patients with autosomal dominant polycystic kidney disease.Am J Kidney Dis2011; 57: 903–7.
16.
LobbedezT., TouamM., EvansD., RyckelynckJ.P., KnebelmanB., VergerC.Peritoneal dialysis in polycystic kidney disease patients. Report from the French peritoneal dialysis registry (RDPLF).Nephrol Dial Transplant2011; 26: 2332–9.
17.
CourivaudC., RoubiouC., Delabrousse, Bresson-VautrinE.C., ChalopinJ.M., DuclouxD.Polycystic kidney size and outcomes on peritoneal dialysis: comparison with hemodialysis.Clin Kidney J2014; 7: 138–43.
18.
JaneiroD., PortolesJ., TatoA.M., López-SánchezP., Del PesoG., RiveraM.Peritoneal dialysis can be an option for autosomal dominant polycystic kidney disease: an observational study.Perit Dial Int2015; 35: 530–6.
19.
YangJ.Y., ChenL., ChaoC.T., PengY.S., ChiangC.K., KaoT.W.Outcome comparisons between patients on peritoneal dialysis with and without polycystic kidney disease.Medicine2015; 94: e2166.
20.
KocY., BasturkT., SakaciT., Atan UcarZ., AhbapE., SevincM.Is peritoneal dialysis a therapeutic option for polycystic kidney disease? 15 years’ experience in a single center.Nephrol Ther2016; 12(4): 215–20.
21.
AbbottK.C., AgodoaL.Y.Polycystic kidney disease at end stage renal disease in the United States; patient characteristics and survival.Clin Nephrol2002; 57: 208–14.
22.
NolphK.D., CutlerS.J., SteinberdS.M., NovakJ.W.Continuous ambulatory peritoneal dialysis in the United States; a three-year study.Kidney Int1985; 28: 198–205.
23.
KaulA., BhadhuariaD., PrasadN., PrasadN., GuptaA., SharmaR.K.Is CAPD a viable option among ADPKD with end stage renal disease population in India? Its outcomes and economics.Saudi J Kidney Dis Transpl2015; 26: 906–11.
24.
HamanoueS., HoshinoJ., SuwabeT., MaruiY., UenoT., KikuchiK.Peritoneal dialysis is limited by kidney and liver volume in autosomal dominant polycystic kidney disease.Ther Apher Dial2015; 19: 207–11.
25.
YangJ.H., ChenL., ChaoC.T., PengY.S., ChiangC.K., KaoT.W.Comparative study of outcomes among patients with polycystic kidney disease on hemodialysis and peritoneal dialysis.Sci Rep2015; 5: 12816.
26.
DurandP.Y., ChanliauJ., GamberoniJ., HestinD., KesslerM.APD: clinical measurement of the maximal acceptable intraperitoneal volume.Adv Perit Dial1994; 10: 63–7.
